Prescription drug · UNAPPROVED DRUG OTHER
TriStart DHA NDC 15370-250
Ascorbic acid 55 mg/1 + 14 more ingredients · Capsule, Liquid filled · Oral · CarWin Pharmaceutical Associates, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 15370-250-30 | 15370025030 | 30 CAPSULE, LIQUID FILLED in 1 BOTTLE, PLASTIC (15370-250-30)Marketed from Jun 1, 2015 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- TriStart DHA
- Generic name (nonproprietary)
- ascorbic acid, cholecalciferol, .alpha.-tocopherol acetate, d-, thiamine hydrochloride, riboflavin, niacin, pyridoxine hydrochloride, levomefolate magnesium, folic acid, cyanocobalamin, iron pentacarbonyl, potassium iodide, magnesium oxide, doconexent, and icosapent
- Active ingredients
- Ascorbic acid — 55 mg/1Cholecalciferol — 1000 [iU]/1.alpha.-tocopherol acetate, D- — 15 [iU]/1Thiamine hydrochloride — 1.3 mg/1Riboflavin — 1.8 mg/1Niacin — 5 mg/1Pyridoxine hydrochloride — 35 mg/1Levomefolate magnesium — 600 ug/1Folic acid — 400 ug/1Cyanocobalamin — 14 ug/1Iron pentacarbonyl — 31 mg/1Potassium iodide — 200 ug/1Magnesium oxide — 30 mg/1Doconexent — 200 mg/1Icosapent — 15 mg/1
- Dosage form
- Capsule, Liquid filled
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- Unapproved drug (other)
- Marketing start
- Listing expires
- Other FDA classes
- Analogs/Derivatives (Chemical/Ingredient)Ascorbic Acid (Chemical structure)Folic Acid (Chemical structure)Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Small Intestine Fluid/Electrolyte Absorption (Physiologic effect)Magnesium Ion Exchange Activity (Mechanism)Nicotinic Acids (Chemical structure)Osmotic Activity (Mechanism)Stimulation Large Intestine Fluid/Electrolyte Secretion (Physiologic effect)Vitamin B 12 (Chemical structure)Vitamin B 6 (Chemical/Ingredient)Vitamin D (Chemical structure)
- Identifiers
- Product ID 15370-250_4889480e-2d59-4dbd-a808-ea7fce24f922SPL ID 4889480e-2d59-4dbd-a808-ea7fce24f922SPL set ID 92ccf7d4-4527-49f0-b890-1a11b5a10086UNII PQ6CK8PD0R, 1C6V77QF41, A7E6112E4N, M572600E5P, TLM2976OFR, 2679MF687A, 68Y4CF58BV, 1VZZ62R081, 935E97BOY8, P6YC3EG204, 6WQ62TAQ6Z, 1C4QK22F9J, 3A3U0GI71G, ZAD9OKH9JC, AAN7QOV9EAUPC 0315370250307
- Pharmacologic class
- Calculi Dissolution Agent; Folate Analog; Nicotinic Acid; Osmotic Laxative; Vitamin B12; Vitamin B6 Analog; Vitamin C; Vitamin D
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N415370025030followed by a unit qualifier and the quantityPackage 15370-0250-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
INDICATIONS TriStart DHA™ is an orally administered multivitamin/multimineral fatty acid dietary supplement indicated to improve the nutritional status of women throughout pregnancy and in the postnatal period for both lactating and nonlactating mothers. TriStart DHA™ can also be beneficial in improving the nutritional status of women prior to conception. This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent disease.
Excerpt only. Read the full label for complete information.